ClinicalTrials.Veeva

Menu

Epidemiology of ST131 in Besançon University Hospital (coliST131)

C

Centre Hospitalier Universitaire de Besancon

Status

Completed

Conditions

Escherichia Coli Infections

Study type

Observational

Funder types

Other

Identifiers

NCT02853708
API/2015/62

Details and patient eligibility

About

The sequence type 131 (ST131) is a predominant lineage among extraintestinal pathogenic Escherichia coli. It plays a major role in the worldwide dissemination of E. coli that produce extended-spectrum beta-lactamase (ESBL). The aim of this study was to describe the epidemiology of ESBL producing ST131clonal group in our university hospital. All patients with an infection due to ESBL E. coli will be prospectively included for a 2-year period. ST131 isolates will be identified and risk factors associated to ST131 will be determined in comparison to non-ST131 ESBL E. coli.

Enrollment

300 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients infected with ESBL producing E. coli

Exclusion criteria

  • Patients known to be carrier or infected in the previous year, patients only colonised with ESBL producing E. coli.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems